Drug reference

Estradiol with medroxyprogesterone

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 826, 827

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

INDIVINA ® TABLETS Menopausal symptoms in women with a uterus whose last menstrual period occurred over 3 years previously | Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 3 years previously ▶BY MOUTH ▶Adult: Initially 1/2.5 mg daily taken continuously, adjust according to response, to be started at end of scheduled bleed if changing from cyclical HRT TRIDESTRA ® Menopausal symptoms in women with a uterus | Osteoporosis prophylaxis in women with a uterus ▶BY MOUTH ▶Adult: 1 tablet daily for 70 days, white tablet to be taken, then 1 tablet daily for 14 days, blue tablet to be taken, then 1 tablet daily for 7 days, yellow tablet to be taken, subsequent courses are repeated without interval

PDF page 826

Safety

Interactions

→Appendix 1: hormone replacement therapy

PDF page 826

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Indivina (Orion Pharma (UK) Ltd) Estradiol valerate 1 mg, Medroxyprogesterone acetate 2.5 mg Indivina 1mg/2.5mg tablets | 84 tablet P £20.58 DT = £20.58 Estradiol valerate 2 mg, Medroxyprogesterone acetate 5 mg Indivina 2mg/5mg tablets | 84 tablet P £20.58 DT = £20.58 Estradiol valerate 1 mg, Medroxyprogesterone acetate 5 mg Indivina 1mg/5mg tablets | 84 tablet P £20.58 DT = £20.58 ▶Tridestra (Orion Pharma (UK) Ltd) Tridestra tablets | 91 tablet P £20.49

PDF page 827

Dose text by age group

Adult

Initially 1/2.5 mg daily taken continuously,

First-line fragment. Read the complete Indications and Dose section above.

PDF page 826

Adult

1 tablet daily for 70 days, white tablet to be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 826

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Estradiol with medroxyprogesterone

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 826, 827

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

PDF page 826

Safety

Interactions

→Appendix 1: hormone replacement therapy

PDF page 826

Dose and formulations

Medicinal Forms

PDF page 827

Dose text by age group

Adult

Initially 1/2.5 mg daily taken continuously,

First-line fragment. Read the complete Indications and Dose section above.

PDF page 826

Adult

1 tablet daily for 70 days, white tablet to be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 826

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.